Your browser doesn't support javascript.
loading
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron, Marie; Chevret, Sylvie; Grob, Jean-Jacques; Beylot-Barry, Marie; Saiag, Philippe; Fléchon, Aude; You, Benoit; Maubec, Eve; Jouary, Thomas; Toulemonde, Elise; Jamme, Philippe; Gambotti, Laëtitia; Lamrani-Ghaouti, Assia; Dupuy, Alain; Lebbe, Céleste; Seguin, Nicole Basset; Houede, Nadine; Leccia, Marie-Thérèse; Le Du, Fanny; de Pontville, Michel; Gaudy-Marquestre, Caroline; Guillot, Bernard; Simon, Clotilde; Marabelle, Aurélien; Mortier, Laurent.
Afiliação
  • Véron M; Department of Dermatology, Claude Huriez Hospital, University Hospital of Lille, France; University School of Medecine Henri Warembourg, Lille, France. Electronic address: marie.veron705@gmail.com.
  • Chevret S; Biostatistics, Saint Louis Hospital, Paris, France.
  • Grob JJ; Department of Dermatology, University Hospital La Timone, Marseille, France; CARADERM Network.
  • Beylot-Barry M; Department of Dermatology, University Hospital of Bordeaux & Translational Research on Oncodermatology and Rare Skin Diseases, Bordeaux Institute of Oncology, INSERM 1312, University of Bordeaux, France; CARADERM Network.
  • Saiag P; Department of Dermatology, Ambroise Paré Hospital, APHP, & EA4340, University of Versailles-SQY and University of Paris-Saclay, France; CARADERM Network.
  • Fléchon A; Department of Oncology, Léon Bérard Center, Lyon, France.
  • You B; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, EA3738 CICLY, Université Claude Bernard Lyon 1, Lyon, France; CARADERM Network.
  • Maubec E; Department of Dermatology, Avicenne Hospital, University Hospital of Paris, France; CARADERM Network.
  • Jouary T; Department of Dermatology, University Hospital of Pau, France; CARADERM Network.
  • Toulemonde E; Department of Dermatology, Claude Huriez Hospital, University Hospital of Lille, France; University School of Medecine Henri Warembourg, Lille, France.
  • Jamme P; Department of Dermatology, Claude Huriez Hospital, University Hospital of Lille, France; University School of Medecine Henri Warembourg, Lille, France.
  • Gambotti L; Institut National Contre le Cancer (INCa), France.
  • Lamrani-Ghaouti A; Department R&D Unicancer, Paris, France.
  • Dupuy A; Department of Dermatology, CHU Rennes.
  • Lebbe C; Université de Paris Cite, Dermato-Oncologie, AP-HP Hôpital Saint Louis, F-75010 Paris, INSERM U976, France; CARADERM Network.
  • Seguin NB; Université de Paris Cite, Dermato-Oncologie, AP-HP Hôpital Saint Louis, F-75010 Paris, INSERM U976, France; CARADERM Network.
  • Houede N; Department of Dermatology, University Hospital of Nimes, France.
  • Leccia MT; Department of Dermatology, University Hospital of Grenoble, France; CARADERM Network.
  • Le Du F; Department of Oncology, Eugène Maquis Center, Rennes, France.
  • de Pontville M; Department of Dermatology, University Hospital of Caen, France; CARADERM Network.
  • Gaudy-Marquestre C; Department of Dermatology, University Hospital La Timone, Marseille, France; CARADERM Network.
  • Guillot B; Department of Dermatology, St Eloi Hospital, University Hospital of Montpellier, France; CARADERM Network.
  • Simon C; Department R&D Unicancer, Paris, France.
  • Marabelle A; Département D'Innovation Thérapeutique et D'Essais Précoces (DITEP), INSERM U1015 & CIC1428, Université Paris Saclay, Gustave Roussy, Villejuif, France.
  • Mortier L; Department of Dermatology, Claude Huriez Hospital, University Hospital of Lille, France; University School of Medecine Henri Warembourg, Lille, France; CARADERM Network; INSERM 41189 / ONCOTHAI.
Eur J Cancer ; 177: 103-111, 2022 12.
Article em En | MEDLINE | ID: mdl-36335780

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article